| 1 |
Andrew Fensome |
Pfizer |
7 |
| 2 |
Bryan R. Hotaling |
The First Years |
4 |
| 3 |
Peter J. Coassin |
Aurora Biosciences |
3 |
| #4 |
Li-Shiang Liang |
Evoqua Water Technologies |
2 |
| #4 |
Gerald R. Benitz |
MIT |
2 |
| #4 |
Vincent Galullo |
Vertex Pharmaceuticals Incorporated |
2 |
| #4 |
Noyan Kinayman |
Anokiwave |
2 |
| #4 |
Thomas V. Sikina |
RTX (Raytheon) |
2 |
| #4 |
Stephen W. Into |
— |
2 |
| #10 |
Carl Beckett |
Covaris |
1 |
| #10 |
Anthony Serino |
Lts Lohmann Therapie-Systeme Ag |
1 |
| #10 |
Kenneth L. Carr |
Meridian Medical Systems |
1 |
| #10 |
Peter Zuk, Jr. |
Hemasure |
1 |
| #10 |
Thomas Mikes |
Agilent Technologies |
1 |
| #10 |
James Fox |
MIT |
1 |
| #10 |
Malcolm Allison |
Novartis Ag |
1 |
| #10 |
F. William French |
Emc |
1 |
| #10 |
Lawrence Berlowitz Tarrant |
Stryker |
1 |
| #10 |
Mark H. Etzel |
AT&T |
1 |
| #10 |
John W. Ketchum |
Qualcomm |
1 |
| #10 |
Michael Kilian |
Emc |
1 |
| #10 |
Marc Sevigny |
Broadcom |
1 |
| #10 |
Thomas P. Monath |
Acambis |
1 |
| #10 |
Philip T. Robinson |
3Com |
1 |
| #10 |
Robert Meyer |
Broadcom |
1 |
| #10 |
Frank Calabresi |
General Instrument |
1 |
| #10 |
Doug Williams |
Diebold |
1 |
| #10 |
Anthony Kvenvold |
— |
1 |
| #10 |
Janet Zimmerman |
The Collaborative Group |
1 |
| #10 |
Jonathan Panek |
Philips |
1 |
| #10 |
Daniel Ziegelmiller |
Empirix |
1 |
| #10 |
Heidi R. Pickreign |
3Com |
1 |
| #10 |
David K. Barton |
RTX (Raytheon) |
1 |